HIV "Elite Controllers" are characterized by a high frequency of memory CD8+CD73+ T cells involved in the antigen-specific CD8+ T-cell response

Journal of Infectious Diseases

Volumn 209, Issue 9, 2014, Pages 1321-1330

  Carrière, Matthieu ^a,b   Lacabaratz, Christine ^a,b   Kök, Ayrin ^a,b   Benne, Clarisse ^a,b   Jenabian, Mohammad Ali ^a,b   Casartelli, Nicoletta ^c   Hüe, Sophie ^a,b   Hocqueloux, Laurent ^d   Lelièvre, Jean Daniel ^a,b   Lévy, Yves ^a,b  

^a HENRI MONDOR HOSPITAL   (France)

^b UNIVERSITÉ PARIS EST CRÉTEIL   (France)

^c CNRS   (France)

^d CENTRE HOSPITALIER RÉGIONAL D ORLÉANS   (France)

Author keywords

activation; CD73; HIV; HIV controller

Indexed keywords

5' NUCLEOTIDASE; ADENOSINE; GAMMA INTERFERON; INTERLEUKIN 2; TUMOR NECROSIS FACTOR ALPHA;

ANTIVIRAL THERAPY; ARTICLE; CD8+ CD73+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL ACTIVATION; CELL EXPANSION; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; ENZYME SYNTHESIS; EX VIVO STUDY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; IMMUNITY; IN VITRO STUDY; INTESTINE; LYMPHOCYTE FUNCTION; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; VIRUS REPLICATION;

ACTIVATION; CD73; CD8+ T-CELL RESPONSE; HIV; HIV CONTROLLER;

5'-NUCLEOTIDASE; CASE-CONTROL STUDIES; CD8-POSITIVE T-LYMPHOCYTES; GPI-LINKED PROTEINS; HIV INFECTIONS; HIV-1; HOST-PATHOGEN INTERACTIONS; HUMANS;

EID: 84898856258     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/jit643     Document Type: Article

References (46)

1. Kahn JO, Walker BD. Acute human immunodeficiency virus type 1 infection. N Engl J Med 1998; 339:33-9
2. Betts MR, Ambrozak DR, Douek DC, et al. Analysis of total human immunodeficiency virus (HIV)-specific CD4(+) and CD8(+) T-cell responses: Relationship to viral load in untreated HIV infection. J Virol 2001; 75:11983-91
3. Appay V, Douek DC, Price DA. CD8+ T-cellefficacy in vaccination and disease. Nat Med 2008; 14:623-8
4. Shacklett BL, Anton PA. HIV infection and gut mucosal immune function: Updates on pathogenesis with implications for management and intervention. Curr Infect Dis Rep 2010; 12:19-27
5. Mowat AM, Viney JL. The anatomical basis of intestinal immunity. Immunol Rev 1997; 156:145-66
6. Hubert JB, Burgard M, Dussaix E, et al. Natural history of serum HIV-1 RNA levels in 330 patients with a known date of infection. The SEROCO Study Group. AIDS 2000; 14:123-31
7. Deeks SG, Walker BD. Human immunodeficiency virus controllers: Mechanisms of durable virus control in the absence of antiretroviral therapy. Immunity 2007; 27:406-16
8. Betts MR, Nason MC, West SM, et al. HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells. Blood 2006; 107:4781-9
9. Zimmerli SC, Harari A, Cellerai C, Vallelian F, Bart PA, Pantaleo G. HIV-1-specific IFN-gamma/IL-2-secreting CD8 T-cells support CD4-independent proliferation of HIV-1-specific CD8T cells. Proc Natl Acad Sci USA 2005; 102:7239-44
10. Saez-Cirion A, Lacabaratz C, Lambotte O, et al. HIV controllers exhibit potent CD8 T-cell capacity to suppress HIV infection ex vivo and peculiar cytotoxic T lymphocyte activation phenotype. Proc Natl Acad Sci USA 2007; 104:6776-81
11. Migueles SA, Osborne CM, Royce C, et al. Lytic granule loading of CD8+ T-cells is required for HIV-infected cell elimination associated with immune control. Immunity 2008; 29:1009-21
12. International HIVCSPereyra F, Jia X, et al. The major genetic determinants of HIV-1 control affect HLA class I peptide presentation. Science 2010; 330:1551-7
13. Airas L, Niemela J, Salmi M, Puurunen T, Smith DJ, Jalkanen S. Differential regulation and function of CD73, a glycosyl- phosphatidylinositollinked 70-kD adhesion molecule, on lymphocytes and endothelial cells. J Cell Biol 1997; 136:421-31
14. Resta R, Yamashita Y, Thompson LF. Ecto-enzyme and signaling functions of lymphocyte CD73. Immunol Rev 1998; 161:95-109
15. Gessi S, Varani K, Merighi S, et al. Adenosine and lymphocyte regulation. Purinergic Signal 2007; 3:109-16
16. Nikolova M, Carriere M, Jenabian MA, et al. CD39/adenosine pathway is involved in AIDS progression. PLOS Pathog 2011; 7:e1002110
17. Raskovalova T, Lokshin A, Huang X, et al. Inhibition of cytokine production and cytotoxic activity of human antimelanoma specific CD8+and CD4+ T lymphocytes by adenosine-protein kinase A type I signaling. Cancer Res 2007; 67:5949-56
18. Airas L, Hellman J, Salmi M, et al. CD73 is involved in lymphocyte binding to the endothelium: Characterization of lymphocyte-vascular adhesion protein 2 identifies it as CD73. J Exp Med 1995; 182: 1603-8
19. Airas L, Niemela J, Jalkanen S. CD73 engagement promotes lymphocyte binding to endothelial cells via a lymphocyte function-Associated antigen-1-dependent mechanism. J Immunol 2000; 165:5411-7
20. Thompson LF, Ruedi JM, Glass A, Low MG, Lucas AH. Antibodies to 5′-nucleotidase (CD73), a glycosyl-phosphatidylinositol-Anchored protein, cause human peripheral blood T-cells to proliferate. J Immunol 1989; 143:1815-21
21. Massaia M, Perrin L, Bianchi A, et al. Human T-cell activation. Synergy between CD73 (ecto-5′-nucleotidase) and signals delivered through CD3 and CD2 molecules. J Immunol 1990; 145:1664-74
22. Metz CN, Brunner G, Choi-Muira NH, et al. Release of GPI-Anchored membrane proteins by a cell-Associated GPI-specific phospholipase D. EMBO J 1994; 13:1741-51
23. Low MG, Prasad AR. A phospholipase D specific for the phosphatidylinositol anchor of cell-surface proteins is abundant in plasma. Proc Natl Acad Sci USA 1988; 85:980-4
24. Peola S, Borrione P, Matera L, Malavasi F, Pileri A, Massaia M. Selective induction of CD73 expression in human lymphocytes by CD38 ligation: A novel pathway linking signal transducers with ecto-enzyme activities. J Immunol 1996; 157:4354-62
25. Scallon BJ, Fung WJ, Tsang TC, et al. Primary structure and functional activity of a phosphatidylinositol-glycan-specific phospholipase D. Science 1991; 252:446-8
26. Mann KJ, Hepworth MR, Raikwar NS, Deeg MA, Sevlever D. Effect of glycosylphosphatidylinositol (GPI)-phospholipase D overexpression on GPI metabolism. Biochem J 2004; 378:641-8
27. Davitz MA, Hom J, Schenkman S. Purification of a glycosyl- phosphatidylinositol-specific phospholipase D from human plasma. J Biol Chem 1989; 264:13760-4
28. Low MG, Huang KS. Factors affecting the ability of glycosylphosphatidylinositol-specific phospholipase D to degrade the membrane anchors of cell surface proteins. Biochem J 1991; 279 (pt 2):483-93
29. Murray JL, Reuben JM, Munn CG, Mansell PW, Newell GR, Hersh EM. Decreased 5′ nucleotidase activity in lymphocytes from asymptomatic sexually active homosexual men and patients with the acquired immune deficiency syndrome. Blood 1984; 64:1016-21
30. Salazar-Gonzalez JF, Moody DJ, Giorgi JV, Martinez-Maza O, Mitsuyasu RT, Fahey JL. Reduced ecto-5′-nucleotidase activity and enhanced OKT10 and HLA-DR expression on CD8 (T suppressor/cytotoxic) lymphocytes in the acquired immune deficiency syndrome: Evidence of CD8 cell immaturity. J Immunol 1985; 135:1778-85
31. Toth I, Le AQ, Hartjen P, et al. Decreased frequency of CD73+CD8+T-cells of HIV-infected patients correlates with immune activation and T-cell exhaustion. J Leukoc Biol 2013; 94:551-61
32. Lambotte O, Boufassa F, Madec Y, et al. HIV controllers: A homogeneous group of HIV-1-infected patients with spontaneous control of viral replication. Clin Infect Dis 2005; 41:1053-6
33. Cerf-Bensussan N, Guy-Grand D, Griscelli C. Intraepithelial lymphocytes of human gut: Isolation, characterisation and study of natural killer activity. Gut 1985; 26:81-8
34. Bas A, Forsberg G, Hammarstrom S, Hammarstrom ML. Utility of the housekeeping genes 18S rRNA, beta-Actin and glyceraldehyde-3-phosphate- dehydrogenase for normalization in real-Time quantitative reverse transcriptase-polymerase chain reaction analysis of gene expression in human T lymphocytes. Scand J Immunol 2004; 59:566-73
35. Dianzani U, Redoglia V, Bragardo M, et al. Co-stimulatory signal delivered by CD73 molecule to human CD45RAhiCD45ROlo (naive) CD8+T lymphocytes. J Immunol 1993; 151:3961-70
36. Zidovec Lepej S, Vince A, Dakovic Rode O, Remenar A, Jeren T. Increased numbers of CD38 molecules on bright CD8+ T lymphocytes in infectious mononucleosis caused by Epstein-Barr virus infection. Clin Exp Immunol 2003; 133:384-90
37. Thomson LF, Ruedi JM, Glass A, et al. Production and characterization of monoclonal antibodies to the glycosyl phosphatidylinositol-Anchored lymphocyte differentiation antigen ecto-5′-nucleotidase (CD73). Tissue Antigens 1990; 35:9-19
38. RazA, Collard JG, InbarM.Decrease in 5′-nucleotidase activity inmalignant transformed and normal stimulated cells. Cancer Res 1978; 38:1258-62
39. Schuler PJM, Bernard JC, Snaze Z, et al. CD4+CD73+ T-cells are associated with lower T-cell activation and CRP levels and are depleted in HIV-1 infection regardless of viral suppression. AIDS 2013; 27:1545-55
40. Christensen LD, Andersen V, Ryder L. Decreased number of CD73 (ecto-5′-nucleotidase) molecules on lymphocytes from patients with primary immunoglobulin deficiencies. Correlation between number of CD73 molecules and T-lymphocyte function in vitro. Scand J Immunol 1996; 44:62-70
41. Mikhailov A, Sokolovskaya A, Yegutkin GG, et al. CD73 participates in cellular multiresistance program and protects against TRAIL-induced apoptosis. J Immunol 2008; 181:464-75
42. McMichael AJ, Borrow P, Tomaras GD, Goonetilleke N, Haynes BF. The immune response during acute HIV-1 infection: Clues for vaccine development. Nat Rev Immunol 2010; 10:11-23
43. Goujard C, Chaix ML, Lambotte O, et al. Spontaneous control of viral replication during primary HIV infection: When is HIV controller status established? Clin Infect Dis 2009; 49:982-6
44. Ruiz-Mateos E, Machmach K, Romero-Sanchez MC, et al. Hepatitis C virus replication in Caucasian HIV controllers. J Viral Hepat 2011; 18: E350-7
45. Beavis PA, Stagg J, Darcy PK, Smyth MJ. CD73: A potent suppressor of antitumor immune responses. Trends Immunol 2012; 33:231-7
46. Jenabian MA, Seddiki N, Yatim A, et al. Regulatory T-cells negatively affect IL-2 production of effector T-cells through CD39/adenosine pathway in HIV infection. PLOS Pathog 2013; 9:e1003319.